SCHEMBL29985409

SCHEMBL29985409

O=C(O)Cc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.73
MAPT P10636 3/20 0.67
CSF1R P07333 3/20 0.66
ROCK2 O75116 1/20 0.66
MAP4K4 O95819 1/20 0.66
LCK P06239 1/20 0.66
RPS6KB1 P23443 1/20 0.66
CDK2 P24941 1/20 0.66
MAPK1 P28482 1/20 0.66
EPHA2 P29317 1/20 0.66
FLT3 P36888 1/20 0.66
FRK P42685 1/20 0.66
CLK2 P49760 1/20 0.66
GSK3A P49840 1/20 0.66
GSK3B P49841 1/20 0.66
LIMK1 P53667 1/20 0.66
STK3 Q13188 1/20 0.66
CAMK2B Q13554 1/20 0.66
CAMK2G Q13555 1/20 0.66
CAMK2D Q13557 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16111563 0.85 PIM1 (1.00) PIM1MAPTCSF1RKDM4EGAA
SCHEMBL12955777 0.84 PIM1 (0.59) PIM1MAPTCSF1RROCK2MAP4K4
SCHEMBL12630093 0.84 PIM1 (0.59) PIM1MAPTCSF1RROCK2MAP4K4
SCHEMBL8923670 0.82 KDM4E (0.55) PIM1MAPTCSF1RROCK2MAP4K4
SCHEMBL4851140 0.81 CSF1R (0.76) PIM1MAPTCSF1RROCK2MAP4K4
SCHEMBL4847744 0.80 MAP2 (0.72) PIM1MAPTCSF1RROCK2MAP4K4
SCHEMBL24095581 0.80 KDM4E (0.79) PIM1MAPTCSF1RROCK2MAP4K4
SCHEMBL9363357 0.80 CSF1R (1.00) PIM1MAPTCSF1RROCK2MAP4K4
SCHEMBL8784678 0.79 PIM1 (0.51) PIM1MAPTCSF1RROCK2MAP4K4
Hydrochloric Acid SCHEMBL4854389 0.79 MAP2 (0.71) PIM1MAPTCSF1RROCK2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220323494-A1 Novel Control Switch GLAXOSMITHKLINE IP DEV LTD (GB) 2022-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220323494-A1 Novel Control Switch TNFRSF9, TNFRSF1A, TNFSF11 PIM1 469/4885MAPT 1826/4885CSF1R 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.